Psychemedics Statistics
Share Statistics
Psychemedics has 5.89M
shares outstanding. The number of shares has increased by 1.53%
in one year.
| Shares Outstanding | 5.89M |
| Shares Change (YoY) | 1.53% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 20.9% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 5,569 |
| FTD / Avg. Volume | 12.99% |
Short Selling Information
The latest short interest is 38.6K, so 0.65% of the outstanding
shares have been sold short.
| Short Interest | 38.6K |
| Short % of Shares Out | 0.65% |
| Short % of Float | 0.87% |
| Short Ratio (days to cover) | 1.92 |
Valuation Ratios
The PE ratio is -4.09 and the forward
PE ratio is null.
Psychemedics's PEG ratio is
-0.01.
| PE Ratio | -4.09 |
| Forward PE | n/a |
| PS Ratio | 0.77 |
| Forward PS | 0.8 |
| PB Ratio | 2.55 |
| P/FCF Ratio | -10.38 |
| PEG Ratio | -0.01 |
Financial Ratio HistoryEnterprise Valuation
Psychemedics has an Enterprise Value (EV) of 17.32M.
| EV / Sales | 0.78 |
| EV / EBITDA | -69.02 |
| EV / EBIT | -11.71 |
| EV / FCF | -10.58 |
Financial Position
The company has a current ratio of 1.45,
with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.45 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | -9.16 |
| Debt / FCF | -1.4 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is -62.26% and Return on Invested Capital is -39.35%.
| Return on Equity | -62.26% |
| Return on Assets | -33.7% |
| Return on Invested Capital | -39.35% |
| Revenue Per Employee | $190,500 |
| Profits Per Employee | $-35,810.34 |
| Employee Count | 116 |
| Asset Turnover | 1.79 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 716K |
| Effective Tax Rate | -20.83% |
Stock Price Statistics
The stock price has increased by 0.75% in the
last 52 weeks. The beta is 0.67, so Psychemedics's
price volatility has been higher than the market average.
| Beta | 0.67 |
| 52-Week Price Change | 0.75% |
| 50-Day Moving Average | 2.13 |
| 200-Day Moving Average | 2.29 |
| Relative Strength Index (RSI) | 50.24 |
| Average Volume (20 Days) | 42,860 |
Income Statement
In the last 12 months, Psychemedics had revenue of 22.1M
and earned -4.15M
in profits. Earnings per share was -0.72.
| Revenue | 22.1M |
| Gross Profit | 8.41M |
| Operating Income | -2.92M |
| Net Income | -4.15M |
| EBITDA | -251K |
| EBIT | -2.92M |
| Earnings Per Share (EPS) | -0.72 |
Full Income StatementBalance Sheet
The company has 1.96M in cash and 2.3M in
debt, giving a net cash position of -334K.
| Cash & Cash Equivalents | 1.96M |
| Total Debt | 2.3M |
| Net Cash | -334K |
| Retained Earnings | -16.77M |
| Total Assets | 9.84M |
| Working Capital | 2.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -1.48M
and capital expenditures -157K, giving a free cash flow of -1.64M.
| Operating Cash Flow | -1.48M |
| Capital Expenditures | -157K |
| Free Cash Flow | -1.64M |
| FCF Per Share | -0.29 |
Full Cash Flow StatementMargins
Gross margin is 38.07%, with operating and profit margins of -13.22% and -18.8%.
| Gross Margin | 38.07% |
| Operating Margin | -13.22% |
| Pretax Margin | -15.56% |
| Profit Margin | -18.8% |
| EBITDA Margin | -1.14% |
| EBIT Margin | -13.22% |
| FCF Margin | -7.41% |
